Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea · Delayed Price · Currency is KRW 4,230.00
-265.00 (-5.90%)
At close: Aug 21, 2026
Seoulin Bioscience Market Cap
Seoulin Bioscience has a market cap or net worth of 38.2 billion as of August 21, 2026. Its market cap has decreased by -36.28% in one year.
Market Cap
38.20B
Enterprise Value
23.10B
Revenue
83.17B
Ranking
n/a
PE Ratio
50.94
Stock Price
4,230.00
ChartMarket Cap Chart
Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 38.20B, a decrease of -45.22%. That is a compound annual growth rate of -2.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 38.20B | -33.52% |
| Dec 30, 2025 | 57.46B | -6.51% |
| Dec 30, 2024 | 61.46B | -21.97% |
| Dec 28, 2023 | 78.77B | -19.25% |
| Dec 29, 2022 | 97.55B | -44.18% |
| Dec 30, 2021 | 174.75B | 62.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 244.10B |
| 3billion | 172.48B |
| GENINUS | 78.78B |
| Cytogen | 78.32B |
| Protia | 61.57B |
| Inventera | 58.21B |
| GC Medical Science | 56.75B |
| HLB Panagene | 51.58B |